PARP1 and leukemia: In leukemia and NSCLC cell lines, the combination of JL189 with ABT-263 after 5 hr induced a much greater increase in the expression of activated caspase-3 fragment and cleavage of PARP-1 compared to each compound alone (Fig. 5D).